1Department of Anesthesia, General Intensive Care and Pain Medicine, Medical University of Vienna, Vienna, Austria.
2Department of Nephrology, Medical University of Vienna, Vienna, Austria.
3 Center for Biomedical Research, Medical University of Vienna, Vienna, Austria.
4Department of Anesthesiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
5Attoquant Diagnostics, Vienna, Austria.
6Center for Anatomy and Cell Biology, Medical University of Vienna, Vienna, Austria.
*See also p. 1411.
Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal’s website (http://journals.lww.com/ccmjournal).
Drs. Mao and Krenn contributed equally.
Supported, in part, by the Department of Anesthesia and General Intensive Care and a grant from Apeptico GmbH to KK.
This study was performed at the Department of Anesthesia and General Intensive Care and Biomedical Research Laboratory, Medical University of Vienna, Vienna, Austria.
dr Ullrich reports travel expenses and honoraria from Biotest, grants from CCORE, Bayer AG, and Biotest, holds a patent (EP 151897774, minimally invasive liquid lung) and equity in CCORE Technology, a medical device company that develops minimally invasive blood purification devices. dr Krenn received funding from Apeptico GmbH and Biotest GmbH. Drs. Poglitsch and Domenig are employed at Attoquant Diagnostics. dr Ullrich’s institution received funding from Apeptico, Bayer AG, Philips, and Biotest; he received funding from Biotest, F4 Pharma, and CCORE Technologies. The remaining authors have disclosed that they do not have any potential conflicts of interest.
For information regarding this article, email: [email protected]
